Bette Jacobs, Ph.D.
Board Member
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bette Jacobs, Ph.D.
Bette Jacobs, Ph.D. is recorded as Board Member at Shuttle Pharmaceuticals Holdings, Inc. (SHPH). Shuttle Pharmaceuticals Holdings, Inc. reported in an 8-K filed November 1, 2022 that Bette Jacobs, Ph.D. was appointed Board, effective October 28, 2022.
“On October 28, 2022, the board of directors (the "Board") of Shuttle Pharmaceuticals Holdings, Inc., a Delaware Corporation (the "Company"), based upon the recommendation of the Board's Nominating and Corporate Governance Committee, approved the appointment of Bette Jacobs, Ph.D. to the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-10-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Shuttle Pharmaceuticals Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Anatoly Dritschilo M.D CEO
- Christopher Cooper CEO, CFO
- Ryan Trasolini CEO
- George Scorsis Chairman, Board Member
- Michael Vander Hoek CFO
- Timothy J. Lorber CFO
- Timothy Lorber CFO
- Anatoly Dritschilo CTO
- Adam Chambers Board Member
- Angel Liriano Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.